Summary

therapeutics discovery, drug development, drug screening, bioinformatics, clinical analysis, patient stratification, cognitive screening

Description

Unravel Biosciences provides decision tools to improve therapeutics development. By leveraging proprietary maps of genetic network interactions and drug-gene interactions, we identify disease-modifying drug targets and generate functional analysis of therapeutics in vitro, in vivo, and in the clinic.

Special details

Automated cognitive and behavioral screening platform, machine learning analysis of biological data, target identification algorithms, pharmacokinetic analysis models

Profile

  • Incorporated in
    Delaware
  • Established since
    2021
  • Main/Branch
    Branch

Address